Log In
Print
BCIQ
Print
Print this Print this
 

Caprelsa, vandetanib (ZD6474)

Also known as: Zactima

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionEGFR and VEGF receptor kinase inhibitor
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2) ; Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1)
Mechanism of ActionVascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) kinase inhibitor; Epidermal growth factor (EGF) receptor 1 (HER1) (ErbB1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today